Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Abad Fernandez

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Opinion in HIV and AIDS|December 19, 2018
Human cytomegalovirus-vectored vaccines against HIVMaria Abad-Fernandez, Nilu Goonetilleke
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 5, 2022
OMIP-087: Thirty-two parameter mass cytometry panel to assess human CD4 and CD8 T cell activation, memory subsets, and helper subsetsAlexis Sponaugle, Maria Abad-Fernandez, Nilu Goonetilleke
Journal of Virology|March 30, 2018
Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal <i>Ex Vivo</i>Carolina Garrido, Maria Abad-Fernandez, Marina Tuyishime, et al.
Journal of Virology|May 20, 2020
Correction for Garrido et al., "Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal <i>Ex Vivo</i>"Carolina Garrido, Maria Abad-Fernandez, Marina Tuyishime, et al.
Bio-Protocol|April 18, 2022
CD8 T Cell Virus Inhibition Assay ProtocolYinyan Xu, Ann Marie Weideman, Maria Abad-Fernandez, et al.
Frontiers in Immunology|January 23, 2023
Corrigendum: Reliable estimation of CD8 T cell inhibition of <i>in vitro</i> HIV-1 replicationYinyan Xu, Ann Marie Weideman, Maria Abad-Fernandez, et al.
Frontiers in Immunology|July 19, 2021
Reliable Estimation of CD8 T Cell Inhibition of <i>In Vitro</i> HIV-1 ReplicationYinyan Xu, Ann Marie Weideman, Maria Abad-Fernandez, et al.
Molecular Therapy. Methods & Clinical Development|September 20, 2019
HIV-Specific T Cell Responses Are Highly Stable on Antiretroviral TherapyYinyan Xu, Ilana M Trumble, Joanna A Warren, et al.
JCI Insight|March 17, 2026
Safety of a tetravalent live dengue virus vaccine in children responding to one serotype onlyLaura J White, Lindsay D Hein, Maria Abad Fernandez, et al.
Research Square|April 25, 2024
Dengue virus IgG and serotype-specific neutralizing antibody titers measured with standard and mature viruses are associated with protectionLeah Katzelnick, Camila Odio, Jedas Daag, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Opinion in HIV and AIDS|December 19, 2018
Human cytomegalovirus-vectored vaccines against HIVMaria Abad-Fernandez, Nilu Goonetilleke
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 5, 2022
OMIP-087: Thirty-two parameter mass cytometry panel to assess human CD4 and CD8 T cell activation, memory subsets, and helper subsetsAlexis Sponaugle, Maria Abad-Fernandez, Nilu Goonetilleke
Journal of Virology|March 30, 2018
Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal <i>Ex Vivo</i>Carolina Garrido, Maria Abad-Fernandez, Marina Tuyishime, et al.
Journal of Virology|May 20, 2020
Correction for Garrido et al., "Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal <i>Ex Vivo</i>"Carolina Garrido, Maria Abad-Fernandez, Marina Tuyishime, et al.
Bio-Protocol|April 18, 2022
CD8 T Cell Virus Inhibition Assay ProtocolYinyan Xu, Ann Marie Weideman, Maria Abad-Fernandez, et al.
Frontiers in Immunology|January 23, 2023
Corrigendum: Reliable estimation of CD8 T cell inhibition of <i>in vitro</i> HIV-1 replicationYinyan Xu, Ann Marie Weideman, Maria Abad-Fernandez, et al.
Frontiers in Immunology|July 19, 2021
Reliable Estimation of CD8 T Cell Inhibition of <i>In Vitro</i> HIV-1 ReplicationYinyan Xu, Ann Marie Weideman, Maria Abad-Fernandez, et al.
Molecular Therapy. Methods & Clinical Development|September 20, 2019
HIV-Specific T Cell Responses Are Highly Stable on Antiretroviral TherapyYinyan Xu, Ilana M Trumble, Joanna A Warren, et al.
JCI Insight|March 17, 2026
Safety of a tetravalent live dengue virus vaccine in children responding to one serotype onlyLaura J White, Lindsay D Hein, Maria Abad Fernandez, et al.
Research Square|April 25, 2024
Dengue virus IgG and serotype-specific neutralizing antibody titers measured with standard and mature viruses are associated with protectionLeah Katzelnick, Camila Odio, Jedas Daag, et al.
Pageof 2